Floatz logo

Trifluridine

Rectum Adenocarcinoma

Sir Run Run Shaw HospitalSmall moleculePhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

39 Active assets in the Rectum Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Fluorouracilum
Merck Sharp & Dohme LLC
Phase 3BBB
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BBB
Xaliplatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Cetuximab
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Pertuzumab
SWOG Cancer Research Network
Phase 2BB

View all 50 →

Same molecule, other indications

Trifluridine is also rated in:

colorectal cancerActive
BB
Indicative · Phase 3
67 / 100
View asset →
rectal cancerActive
BB
Indicative · Phase 2
67 / 100
View asset →
colorectal adenocarcinomaActive
BB
Indicative · Phase 3
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →